# uniQure N.V.

Type: Company (QURE)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/uniqure-nv
Canonical HTML page: https://gethealthbrief.com/entity/uniqure-nv

## Recent coverage (1 stories)

### UniQure Surges 78% as FDA Greenlights BLA for Huntington's Gene Therapy AMT-130
2026-07-12 05:40:15 · Sentiment: Strongly positive · Impact: 8/10 · Sources: 2

The FDA’s decision to accept existing AMT-130 clinical data for a BLA submission could fast-track the first disease-modifying treatment for Huntington’s disease, with major implications for healthcare systems, payers, and patients.
Full story: https://gethealthbrief.com/story/uniqure-surges-78-fda-huntingtons-gene-therapy-health

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.